HIF-1α has been under investigation as an anti-tumor strategy but targeting HIF-1α directly in the NK cell could potentially be disadvantageous by impairing tumor killing and NK infiltration Krzywinska et al., 2017. This evidence concerns the gene HIF1A and neoplasm.